|
Please
download and print the PDF file below:
|
|
|
|
Susan M. Hossli, MSN, RN
|
Susan M. Hossli, MSN, RN, is Vice President,
Clinical Marketing, The Synephros Group,
Madison, WI. She is a member of ANNA’s Windy
City Chapter.
|
Intradialytic hypotension (IDH) is one of the most common complications of hemodialysis treatment.
Incidence of IDH varies from 10% to 50% of hemodialysis treatments. Numerous publications
address the pathophysiology, effect of frequent episodes, and clinical management of
IDH, but no recent publication has studied how IDH is managed in dialysis clinics. Interviews
and a mail survey were conducted to develop a better understanding of the clinical issues and
concerns surrounding the management of hemodialysis patients who experience episodes of
IDH. Results of the survey indicate that IDH is prevalent and that clinical management is protocol-
driven and consistent with treatment recommendations in the literature.
|
|
CE
RELATED INFORMATION |
|
This
offering for 1.0 contact
hours is being provided by
the
American
Nephrology Nurses Association
(ANNA), which
is accredited as a provider
and approver of continuing
education in nursing by
the American Nurses
Credentialing Center-Commission
on Accreditation (ANCCCOA).
This educational activity
is approved by most states
and specialty organizations
that recognize the ANCC-COA
accreditation process. ANNA
is an approved provider of
continuing education in nursing
by the California Board of
Registered Nursing, BRN Provider
No. 00910; and the Kansas
State Board of Nursing, Provider
No. LT0148-0738. This offering
is accepted for RN and LPN
relicensure in Kansas
|
|
Goal:
Examine the need for further research about the prevalence, and the clinical management,
of intradialytic hypotension (IDH).
Objectives:
1.
Relate the stated incidence of intradialytic hypotension (IDH) as a complication of
hemodialysis to unit protocols that should exist.
2. Describe the protocols for management of intradialytic hyportension that are most
commonly reported.
3. Analyze the need for further research into the inicidence and management of intradialytic
hypotension.
|
AUTHOR DISCLOSURE
STATEMENT |
Susan M. Hossli, MSN, RN has
no conflicts of interest to disclose.
|
ANNA and HDCN CE POLICY STATEMENTS |
The CE policy and disclosure statements of the American Nephrology
Nurses' Association are given in detail on the Symposium
Home Page. The CE policy statements of HDCN are listed on
this page. |